title: Mirabegron the first β3-adrenoceptor agonist for overactive bladder (OAB): a summary of the phase III studies.
authors.affiliation: Department of Urology, The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield, UK. c.r.chapple@shef.ac.uk.
authors.forename: Christopher
authors.initials: C
authors.lastname: Chapple
mesh_terms: D000083:Acetanilides / Q000008:administration & dosage*; D058667:Adrenergic beta-3 Receptor Agonists / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D013844:Thiazoles / Q000008:administration & dosage*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D000083:Acetanilides; D058667:Adrenergic beta-3 Receptor Agonists; D013844:Thiazoles; C520025:mirabegron